Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,163 | 304 | 99.0% |
| Education | $75.00 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,589 | 71 | $0 (2024) |
| Lundbeck LLC | $818.73 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $736.69 | 28 | $0 (2024) |
| Alkermes, Inc. | $609.14 | 23 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $585.62 | 23 | $0 (2024) |
| ITI, Inc. | $565.17 | 24 | $0 (2023) |
| Axsome Therapeutics, Inc. | $415.70 | 24 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $368.36 | 16 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $284.93 | 11 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $277.85 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,276 | 84 | ABBVIE INC. ($523.55) |
| 2023 | $2,813 | 123 | ABBVIE INC. ($780.49) |
| 2022 | $2,058 | 92 | Janssen Pharmaceuticals, Inc ($311.46) |
| 2021 | $90.64 | 6 | Alkermes, Inc. ($74.91) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: CNS | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $32.20 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.95 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.97 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Neuropsychiatry | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $80.21 | General |
| Category: CNS | ||||||
| 10/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Neuropsychiatry | ||||||
| 10/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: PSYCHIATRY | ||||||
| 09/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $105.92 | General |
| Category: CNS | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 272 | 751 | $71,125 | $36,308 |
| 2022 | 4 | 323 | 660 | $61,050 | $36,537 |
| 2021 | 1 | 18 | 190 | $80,627 | $17,382 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 101 | 337 | $33,700 | $19,757 | 58.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 135 | 369 | $27,675 | $12,395 | 44.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 21 | 30 | $3,750 | $2,529 | 67.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 15 | 15 | $6,000 | $1,628 | 27.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 120 | 282 | $28,200 | $17,852 | 63.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 158 | 313 | $19,775 | $12,163 | 61.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 27 | 47 | $5,875 | $4,183 | 71.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 18 | 18 | $7,200 | $2,339 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 190 | $80,627 | $17,382 | 21.6% |
About Hillary Du
Hillary Du is a Physician Assistant healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1720631492.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hillary Du has received a total of $7,238 in payments from pharmaceutical and medical device companies, with $2,276 received in 2024. These payments were reported across 305 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($7,163).
As a Medicare-enrolled provider, Du has provided services to 613 Medicare beneficiaries, totaling 1,601 services with total Medicare billing of $90,228. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Boston, MA
- Active Since 07/22/2019
- Last Updated 02/11/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1720631492
Products in Payments
- VRAYLAR (Drug) $1,589
- REXULTI (Drug) $921.43
- CAPLYTA (Drug) $850.10
- INGREZZA (Drug) $585.62
- INVEGA SUSTENNA (Drug) $452.42
- ARISTADA (Drug) $428.31
- Auvelity (Drug) $415.70
- SPRAVATO (Drug) $254.88
- HETLIOZ (Drug) $245.11
- ABILIFY MAINTENA (Drug) $225.26
- AZSTARYS (Drug) $141.03
- JORNAY PM (Drug) $111.98
- AUSTEDO (Drug) $110.05
- LYBALVI (Drug) $105.92
- Azstarys (Drug) $97.34
- TRINTELLIX (Drug) $75.31
- VIVITROL (Drug) $74.91
- UZEDY (Drug) $64.08
- LATUDA (Drug) $57.50
- Austedo XR (Drug) $45.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Boston
Andrea Milligan, P.a.-C, P.A.-C
Physician Assistant — Payments: $46,222
Lauren Rousseau, Pa-C, PA-C
Physician Assistant — Payments: $24,236
Shari Tomasetti, Pa, PA
Physician Assistant — Payments: $10,440
Tiffany Andrade, Pa-C, PA-C
Physician Assistant — Payments: $8,438
Margaret Naclerio
Physician Assistant — Payments: $8,434
Jerene Bitondo, Pa, PA
Physician Assistant — Payments: $5,645